A new insight into fecal hemoglobin concentration-dependent predictor for colorectal neoplasia

International Journal of Cancer

Volumn 135, Issue 5, 2014, Pages 1203-1212

  Yen, Amy Ming Fang ^a   Chen, Sam Li Sheng ^a   Chiu, Sherry Yueh Hsia ^b   Fann, Jean Ching Yuan ^c   Wang, Po En ^d   Lin, Sheng Che ^e   Chen, Yao Der ^e   Liao, Chao Sheng ^f,g   Yeh, Yen Po ^h   Lee, Yi Chia ⁱ   Chiu, Han Mo ⁱ   Chen, Hsiu His ^j  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c KAINAN UNIVERSITY   (Taiwan)

^d Keelung City Public Health Bureau   (Taiwan)

^e Tainan City Health Bureau   (Taiwan)

^f SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^g FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^h Changhua County Public Health Bureau   (Taiwan)

ⁱ NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^j NATIONAL TAIWAN UNIVERSITY   (Taiwan)

more..

Author keywords

accelerated failure time model; adenoma; colorectal cancer; fecal hemoglobin concentration; predictive model

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL TUMOR; COMMUNITY PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EXTERNAL VALIDITY; FECAL HEMOGLOBIN CONCENTRATION; FECAL IMMUNOCHEMICAL TEST; FECES LEVEL; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; POPULATION RESEARCH; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STATISTICAL MODEL; TAIWAN; VALIDATION STUDY;

ACCELERATED FAILURE TIME MODEL; ADENOMA; COLORECTAL CANCER; FECAL HEMOGLOBIN CONCENTRATION; PREDICTIVE MODEL;

AGED; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HEMOGLOBINS; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; RISK FACTORS;

EID: 84902540129     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28748     Document Type: Article

References (28)

1. Saito H, Soma Y, Koeda J, et al. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer 1995; 61: 465-9.
2. Yang KC, Liao CS, Chiu YH, et al. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan. J Med Screen 2006; 13 (Suppl 1): S8-13.
3. Zappa M, Castiglione G, Paci E, et al. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experience. Int J Cancer 2001; 92: 151-4.
4. Castiglione G, Grazzini G, Miccinesi G, et al. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood. J Med Screen 2002; 9: 99-103.
5. Grazzini G, Castiglione G, Ciabattoni C, et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev 2004; 13: 19-26.
6. Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007; 146: 244-55.
7. van Rossum LG, van Rijn AF, Laheij RJ, et al. Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. Br J Cancer 2009; 101: 1274-81.
8. Hol L, Wilschut JA, van Ballegooijen M, et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 2009; 100: 1103-10.
9. Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010; 59: 62-8.
10. Parra-Blanco A, Gimeno-García AZ, Quintero E, et al. Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. J Gastroenterol 2010; 45: 703-12.
11. Zorzi M, Fedato C, Grazzini G, et al. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy. Gut 2011; 60: 944-9.
12. Terhaar sive Droste JS, Oort FA, van der Hulst RW, et al. Higher fecal immunochemical test cutoff levels: lower positivity rates but still acceptable detection rates for early-stage colorectal cancers. Cancer Epidemiol Biomarkers Prev 2011; 20: 272-80.
13. Chen LS, Yen AM, Chiu SY, et al. Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort. Lancet Oncol 2011; 12: 551-8.
14. Kirkegaard H, Johnsen NF, Christensen J, et al. Association of adherence to lifestyle recommendations and risk of colorectal cancer: a prospective Danish cohort study. BMJ 2010; 341: c5504.
15. Odegaard AO, Koh WP, Yu MC, et al. Body mass index and risk of colorectal cancer in Chinese Singaporeans: the Singapore Chinese Health Study. Cancer 2011; 117: 3841-49.
16. Ortiz AP, Thompson CL, Chak A, et al. Insulin resistance, #central obesity, and risk of colorectal adenomas. Cancer 2012; 118: 1774-81.
17. Potter JD,. Colorectal cancer: molecules and populations. J Natl Cancer Inst 1999; 91: 916-32.
18. Shin A, Hong CW, Sohn DK, et al. Associations of cigarette smoking and alcohol consumption with advanced or multiple colorectal adenoma risks: a colonoscopy-based case-control study in Korea. Am J Epidemiol 2011; 174: 552-62.
19. Chen TH, Chiu YH, Luh DL, et al. Taiwan Community-based Integrated Screening Group. Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer 2004; 100: 1734-43.
20. Chiu YH, Chen LS, Chan CC, et al. Health information system for community-based multiple screening in Keelung, Taiwan (Keelung Community-based Integrated Screening No 3). Int J Med Inform 2006; 75: 369-83.
21. Chen LS, Liao CS, Chang SH, et al. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16). J Med Screen 2007; 14: 191-9.
22. Brener H, Haug U, Hundit S,. Sex differences in performance of fecal occult blood testing. Am J Gastroenterol 2010; 105: 2457-64.
23. Malila N, Oivanen T, Malminiemi O, et al. Test, episode and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design. BMJ 2008; 337: a2261.
24. Muto T, Bussey HJ, Morson BC,. The evolution of the cancer of colon and rectum. Cancer 1975; 36: 2251-70.
25. Steele RJ, McClements P, Watling C, et al. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut 2012; 61: 576-81.
26. Wilschut JA, Hol L, Dekker E, et al. Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. Gastroenterology 2011; 141: 1648-55.
27. Wilson JMG, Jungner G,. Principles and practice of screening for disease. WHO Chronicle, Geneva: World Health Organisation 1968; 22: 473, Public Health Papers, 34.
28. Lansdorp-Vogelaar I, Knudsen AB, Brenner H,. Cost-effectiveness of colorectal cancer screening. Epidemiol Rev 2011; 33: 88-100.